| |
Panel Discussion
| Release Date: January 13, 2009 |
Expiration Date: January 13, 2011 |
Technical Requirements
(will appear in new window)
Estimated Time of Completion |
45 minutes
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity may be submitted for American Osteopathic Association Continuing Medical Education credit in Category 2.
|
| Description |
The webcast series is repurposed from the Platelet Response in Acute Coronary Syndrome symposium held October 18, 2008, in Cleveland, Ohio. This series presents an overview of new and up-to-date research on the management of patients with ACS. It is designed to increase knowledge of current therapeutic strategies, cardiac assessment and diagnosis, and biologic platelet responses, with the ultimate goal of improving the care of cardiac patients. |
| Objectives |
At the conclusion of this activity, the participant will be able to:
- Discuss the importance of platelet response in patients with the ACS.
- Explain the recommendations and supporting rationale for use of antiplatelet therapy in ACS Management.
- Describe the results of key trials of antiplatelet therapies, both completed and ongoing, and their effects on clinical practice.
|
Target Audience |
Cardiologists, emergency medicine physicians, primary care physicians, and healthcare practitioners (including nurse practitioners and physician assistants) with an interest in acute coronary artery disease. |
Accreditation |
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit. |
Activity Directors |
Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FAHA
Chief of Cardiology
VA Boston Healthcare System
Director, Integrated Interventional Cardiovascular Program
Brigham & Women’s Hospital
VA Boston Healthcare System
Senior Investigator, TIMI Group
Boston, MA
W. Frank Peacock, MD, FACEP
Vice Chair
Emergency Medicine Institute
Cleveland Clinic
Cleveland, OH
|
Faculty |
John H. Alexander, MD, MHS, FACC;
Kandice Kottke-Marchant, MD, PhD;
Marc S. Sabatine, MD, MPH
|
Faculty Disclosure |
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| John H. Alexander, MD |
| |
Consulting |
Adolor;
Daiichi Sankyo;
Medicure;
NIH; Novartis
|
| |
Research |
Bristol-Myers Squibb;
Medicure;
Medtronic Japan;
Millenium Pharmaceuticals;
NIH;
Regado Sciences; Schering-Plough
|
| |
Equity |
Millenium Pharmaceuticals |
| |
| Deepak L. Bhatt, MD |
|
Research |
Bristol-Myers Squibb; Eisai;
Ethicon; Heartscape; Sanofi-Aventis; The Medicines Company
|
| |
Speaker's Bureau |
Bristol-Myers Squibb; Sanofi-Aventis; The Medicines Company
|
| |
Teaching & Speaking |
AstraZeneca;
Bristol-Myers Squibb;
Centocor;
Eisai;
Eli Lilly;
GlaxoSmithKline; Millennum;
Paringenix;
PDL;
Sanofi Aventis;
Schering-Plough;
Takeda;
The Medicines Company; TNS Healthcare
|
| |
Expert Witness |
AstraZeneca;
Bristol-Myers Squibb; Centocor;
Eisai; Eli Lilly; GlaxoSmithKline; Millennum;
Paringenix;
PDL;
Sanofi-Aventis;
Schering-Plough;
Takeda; The Medicines Company; TNS Healthcare
|
| |
Consulting/Advisory Board |
Astellas;
AstraZeneca;
Bayer;
Bristol-Myers Squibb; Cardax;
Centocor;
Cogentus;
Daiichi Sankyo;
Eisai;
Eli Lilly;
GlaxoSmithKline; Johnson and Johnson; McNeil;
Medtronic;
Millenium;
Molecular Insights;
Otsuka;
Paringenix;
PDL;
Philips;
Portola;
Sanofi-Aventis;
Schering-Plough;
Scios;
Takeda;
The Medicines Company; TNS Healthcare; Vertex
|
| |
Institution/Employer |
Abraxis;
Alexion Pharma;
AstraZeneca;
Atherogenics;
Aventis;
Biosense Webster;
Biosite;
Boehringer Ingelheim; Boston Scientific;
Bristol-Myers Squibb;
Cardionet;
Centocor;
Converge Medical Inc.; Cordis;
Dr. Reddy’s; Edwards Lifesciences;
Esperion;
GE Medical;
Genentech;
Gilford;
GSK;
Guidant;
J&J;
Kensey-Nash Lilly; Medtronic;
Merck;
Mytogen;
Novartis;
Novo Nordisk;
Orphan Therapeutics;
P&G Pharma;
Pfizer;
Roche;
Sankyo;
Sanofi-Aventis;
Schering-Plough;
Scios;
St. Jude Medical;
Takeda;
TMC;
VasoGenix; Viacor |
| |
| Marc S. Sabatine, MD, MPH |
| |
Consulting |
Bristol-Myers Squibb; Sanofi-Aventis
|
| |
Research |
Daiichi Sankyo;
Sanofi-Aventis; Schering-Plough
|
| |
Teaching & Speaking |
Bristol-Myers Squibb;
Sanofi-Aventis |
The following faculty has indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Kandice Kottke-Marchant, MD, PhD
W. Frank Peacock, MD, FACEP
|
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges an educational grant for support of this activity from:
Daiichi Sankyo, Inc. and Eli Lilly and Company
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education and UNITECH Communications®.
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
|
